Harbour Investments, Inc. Neogenomics Inc Transaction History

Harbour Investments, Inc.

$3.14 Billion
Q3 2024

A detailed history of Harbour Investments, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Harbour Investments, Inc. holds 6,692 shares of NEO stock, worth $103,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,692

Previous 6,942 3.6%

Holding current value

$103,458

Previous $96,000 2.08%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$13.4 - $17.73 $3,350 - $4,432	-250 Reduced 3.6%	6,692 $98,000
Q1 2024 Jul 22, 2024	SELL	$14.06 - $16.79 $8,140 - $9,721	-579 Reduced 7.7%	6,942 $109,000
Q3 2023 Nov 15, 2023	SELL	$12.15 - $17.85 $9,598 - $14,101	-790 Reduced 9.51%	7,521 $92,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $3,567 - $5,016	-253 Reduced 2.95%	8,311 $133,000
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $2,272 - $4,862	-250 Reduced 2.84%	8,564 $149,000
Q4 2022 Feb 15, 2023	SELL	$6.45 - $12.07 $6,837 - $12,794	-1,060 Reduced 10.74%	8,814 $81,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $14,543 - $28,778	-2,060 Reduced 17.26%	9,874 $80,000
Q4 2021 Feb 16, 2022	SELL	$30.49 - $48.49 $131,107 - $208,507	-4,300 Reduced 26.49%	11,934 $407,000
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $5,082 - $6,407	-122 Reduced 0.75%	16,234 $783,000
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $18,676 - $26,361	510 Added 3.22%	16,356 $739,000
Q1 2021 Aug 17, 2021	BUY	$41.56 - $59.88 $650,580 - $937,361	15,654 Added 8153.13%	15,846 $764,000
Q1 2021 May 12, 2021	BUY	$41.56 - $59.88 $7,979 - $11,496	192 New	192 $9,000

Others Institutions Holding NEO

# of Institutions

276

Shares Held

127M

Call Options Held

581K

Put Options Held

115K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.94B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.

Account

Harbour Investments, Inc. Neogenomics Inc Transaction History